Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Keep thinking the shares they may own will be passed onto you as a shareholder in a scam, keep thinking that. Watch and learn. #bagholder and numbers don’t lie that’s why they gagged the TA to hide how big the SS is. #FRAUD #SCAM
I agree and wish it would have happen 2 years ago. They are liars and scammers. I cannot wait until this is shut down or the approved RS happens.
There is NO sister anything. MSPC scammers own shares there does not make that a sister to this scam. And those investors over there won’t touch this scam. They actually sold here and went there. Why would they touch this NO BID scam for months with a SS that became so large they gagged the TA to hide it from investors. #fakenews #MSPCscsm
104 million +
Bahahaha! That’s funny af. This SS is to fat pig it cannot move.
It’s been hitting .000001 for months while at no bid. Scams do that all the time.
Grow up
They are liars! Second MSPC shareholders do not own that plain and simple because all have been lied to. Why do u think this has not moved in two years and NO BID. Math 101 if real Money believed this it would not be at no bid. Case closed
Not happening! This is a diluted scam at no bid for months. That other company has no effect on this pos. But keep wishing lmao. And your right numbers don’t lie about how bloated this SS is that it cannot move. The illegals running MSPC do not care about shareholders. Watch and learn.
NO BID for months and you can see 2s? Bahahaha, pump pump so can dump the bag onto someone else!
They will look and run! They will see the SS was a fat pig before they gagged they TA. This has been happening for two years and investors over there won’t look over hear. Keep pumping and wishing. $MSPC scam already made many bag holders here.
Many unhappy bag holders from this scam $MSPC
Bahaha for two years been hearing this and it’s been NO BID and hitting 000001 lmao
R.I.P. POS scam $MSPC
000001 LMAO
Another day NO VOLUME NO BID lmao even after news
When is this CA law suppose to be voted on that I heard about on this board??
Sorry but I don’t think it will happen. They diluted so much and gagged the TA so its a pig that won’t fly.
And boom just like I said and after mentioning zero volume over half the day someone at the Scam company would purchase $100 worth just to make it look like volume. LMAO at these illegal idiots.
ZERO Volume after all the news LMAO. Smart money know this is a scam run by illegals. But soon as the scammers see this post they will make a little volume lol
$MSPC news and .000001 NO BID. They use twitter to announce news of another company they have some shares in ans it never ever makes this pps move. Scam pos illegals running a penny scam.
This is not MSPC new and it will. It make pps move. Scam
Bahahaha $MSPC doing well for all the bag holders? Lmao
Canada ETF not USA
Weed being legal nation wide would raise weed stocks. I don’t think anyone is waiting on the FDA to approve a MJ drug.
Sorry for your loss!
Told you all about this scam but nobody would listen to me. Lmao
Bahahaha $MSPC. Didn’t you say things have been warming up for like the past two years?
Not going to happen until agate then approved reverse split.
Tell them at TD u know ppl who sold and TD lifted the restriction even when they weren’t current with their financials. Someone there is lying to u is my guess.
I wonder why when I sold my shares they didn’t file with the SEC and I was still able to sell them using TD Ameritrade?
Would you like me to send you an email of my trade confirmation that I sold my shares TD is who I have and they took the restriction off over a year ago. And I literally just sold those shares a few weeks back with no problem whatsoever so there’s something with this story and I’m not sure what.
Sold my PURA weeks ago. This is your brokers fault. TD cleared mine without me even asking.
Yes mine as well and I had them reposted after reporting the issue. I was posting news on laws to be passed today and they kept deleting them.
POLITICSCongress Will Debate Two Bills To Legalize Marijuana At Hearing With DEA Witness Next WeekPublished 12 hours ago on January 10, 2020By Kyle Jaeger
SHARETWEET
A congressional committee will debate two bills to federally legalize marijuana and several other pieces of cannabis research legislation next week, according to a briefing memo obtained by Marijuana Moment on Friday.
A House Energy and Commerce subcommittee is scheduled to hold a hearing on various reform proposals on Wednesday, with witnesses from the Drug Enforcement Administration (DEA), Food and Drug Administration (FDA) and National Institute on Drug Abuse (NIDA) set to testify.
This comes months after the House Judiciary Committee held a historic vote approving a comprehensive legalization bill sponsored by the panel’s chairman, Rep. Jerrold Nadler (D-NY). That legislation—the Marijuana Opportunity, Reinvestment and Expungement (MORE) Act—will be one of two descheduling bills the Energy and Commerce Subcommittee on Health will take up.
The memo starts by providing context on the state of cannabis policy in the U.S., outlining research restrictions imposed under the Controlled Substances Act (CSA), the legalization of industrial hemp, past petitions to reschedule cannabis and public health issues.
DEA Senior Policy Advisor Matthew Strait, FDA Deputy Director for Regulatory Programs Douglas Throckmorton and NIDA Director Nora Volkow are listed as witnesses for the hearing.
Here are the bills that the committee will consider next week:
Marijuana Opportunity Reinvestment and Expungement (MORE) Act
The MORE Act would federally deschedule cannabis, expunge the records of those with prior marijuana convictions and impose a five percent tax on sales, revenue from which would be reinvested in communities most impacted by the drug war.
It would also create a pathway for resentencing for those incarcerated for marijuana offenses, as well as protect immigrants from being denied citizenship over cannabis and prevent federal agencies from blocking public benefits or security clearances due to its use.
Marijuana Freedom and Opportunity Act
This bill, sponsored by Rep. Hakeem Jeffries (D-NY), would federally deschedule marijuana, set aside funding for minority and women-owned cannabis businesses and provide grants to help people expunge prior marijuana convictions. Senate Minority Leader Chuck Schumer (D-NY) is the lead sponsor of a companion Senate bill.
Medical Cannabis Research Act of 2019
The Medical Cannabis Research Act, sponsored by Rep. Matt Gaetz (R-FL), would require the Justice Department to approve additional manufacturers of research-grade marijuana, protect research institutions interested in conducting studies on cannabis and authorize the U.S. Department of Veterans Affairs to inform patients about federally approved cannabis studies that they can participate in.
Medical Marijuana Research Act of 2019
A bipartisan group of House members, led by Rep. Earl Blumenauer (D-OR), introduced the bill last year. It would simplify the registration process for researchers interested in studying cannabis and allow certified scientists to obtain research-grade cannabis from private manufacturers.
Legitimate Use of Medicinal Marijuana Act
This legislation, from Rep. Morgan Griffith (R-VA), would move marijuana from Schedule I to Schedule II under the CSA and clarify that the federal government cannot “prohibit or otherwise restrict” state-legal use, possession, transportation, production and distribution of medical cannabis.
Veterans Medical Marijuana Safe Harbor Act
Rep. Barbara Lee (D-CA) is the sponsor of the Veterans Medical Marijuana Safe Harbor Act, a bill that would make it legal under federal law for military veterans to “use, possess, or transport medical marijuana” in state-legal systems. It would also allow Department of Veterans Affairs (VA) doctors to issue medical cannabis recommendations to their patients.
POLITICSFDA Would Be Required To Allow CBD Product Marketing Under New Bipartisan BillPublished 3 hours ago on January 14, 2020By Kyle Jaeger
SHARETWEET
A bipartisan coalition of lawmakers have introduced a new bill that would allow for hemp-derived CBD to be lawfully marketed as a dietary supplement.
While hemp and its derivatives were federally legalized under the 2018 Farm Bill, the Food and Drug Administration (FDA) is still in the process of developing regulations that would let businesses sell it in the food supply or as nutritional supplements. Former FDA Commissioner Scott Gottlieb said that rulemaking could take years without congressional action.
This legislation, filed on Monday, could be one way to resolve the problem, in that it amends the Federal Food, Drug and Cosmetic Act to include CBD in the definition of dietary supplements.
Rep. Collin Peterson (D-MN), chairman of the House Agriculture Committee, filed the bill. Initial cosponsors include Reps. Thomas Massie (R-KY), James Comer (R-KY) and Chellie Pingree (D-ME).
“The last two Farm Bills were landmark successes for hemp, but we are still very early in this process, and growers need regulatory certainty,” Peterson said in a press release. “This bill will allow FDA to regulate CBD that comes from hemp as a dietary supplement, providing a pathway forward for hemp-derived products.”
Massie told Marijuana Moment that he’s “excited to be an original cosponsor of this bill.”
“Bipartisan allies in Congress and in the grassroots have worked hard for many years to pave the way for hemp legalization,” the congressman said. “In its first year, Kentucky’s industrial hemp industry added hundreds of new jobs and $100 million to the state’s economy! I’m confident H.R. 5587 will be another step in the right direction for industrial hemp.”
As it stands, FDA has said it is using enforcement discretion when it comes to CBD products that are already widely available in markets across the U.S. Only businesses making especially outlandish claims about the therapeutic benefits of the cannabis products are being targeted for the time being, with the agency sending a series of warning letters to select companies.
Numerous lawmakers, including Senate Majority Leader Mitch McConnell (R-KY), have made clear to FDA that Congress intended to allow CBD products to be marketed when it passed the legalization provision, and they’ve urged the agency to expeditiously enact regulations allowing for that activity.
Eric Steenstra, president of the advocacy group Vote Hemp, said in an email blast to supporters that the organization “supports this important new bill which will help provide clarity to the marketplace and ensure that CBD supplements can be marketed and sold nationwide.”
“We urge Congress to pass this legislation quickly and FDA to regulate hemp derived CBD the same as any other supplement under existing regulations,” he said.
The bill, which has been referred to the Agriculture and Energy and Commerce Committees, also includes a provision that would require the U.S. Department of Agriculture (USDA) to study the “regulatory and market barriers for farmers engaged in hemp production.”
Specifically, the department would be required to research the costs of implementing a hemp testing program, the costs of destroying hemp with excess THC content, the “feasibility” of the testing timeline farmers must follow and “other known or potential challenges” related to participation in a domestic hemp market. The department would have to issue a report on its findings within one year of the bill’s enactment.
USDA also became responsible for creating new rules for hemp since the crop was legalized, and it issued an interim final rule outlining proposed regulations in October. Several lawmakers and industry stakeholders have weighed in and recommended certain changes to ensure that the hemp industry isn’t unduly restricted.
Wednesday Vote?
POLITICSCongress Will Debate Two Bills To Legalize Marijuana At Hearing With DEA Witness Next WeekPublished 12 hours ago on January 10, 2020By Kyle Jaeger
SHARETWEET
A congressional committee will debate two bills to federally legalize marijuana and several other pieces of cannabis research legislation next week, according to a briefing memo obtained by Marijuana Moment on Friday.
A House Energy and Commerce subcommittee is scheduled to hold a hearing on various reform proposals on Wednesday, with witnesses from the Drug Enforcement Administration (DEA), Food and Drug Administration (FDA) and National Institute on Drug Abuse (NIDA) set to testify.
This comes months after the House Judiciary Committee held a historic vote approving a comprehensive legalization bill sponsored by the panel’s chairman, Rep. Jerrold Nadler (D-NY). That legislation—the Marijuana Opportunity, Reinvestment and Expungement (MORE) Act—will be one of two descheduling bills the Energy and Commerce Subcommittee on Health will take up.
The memo starts by providing context on the state of cannabis policy in the U.S., outlining research restrictions imposed under the Controlled Substances Act (CSA), the legalization of industrial hemp, past petitions to reschedule cannabis and public health issues.
DEA Senior Policy Advisor Matthew Strait, FDA Deputy Director for Regulatory Programs Douglas Throckmorton and NIDA Director Nora Volkow are listed as witnesses for the hearing.
Here are the bills that the committee will consider next week:
Marijuana Opportunity Reinvestment and Expungement (MORE) Act
The MORE Act would federally deschedule cannabis, expunge the records of those with prior marijuana convictions and impose a five percent tax on sales, revenue from which would be reinvested in communities most impacted by the drug war.
It would also create a pathway for resentencing for those incarcerated for marijuana offenses, as well as protect immigrants from being denied citizenship over cannabis and prevent federal agencies from blocking public benefits or security clearances due to its use.
Marijuana Freedom and Opportunity Act
This bill, sponsored by Rep. Hakeem Jeffries (D-NY), would federally deschedule marijuana, set aside funding for minority and women-owned cannabis businesses and provide grants to help people expunge prior marijuana convictions. Senate Minority Leader Chuck Schumer (D-NY) is the lead sponsor of a companion Senate bill.
Medical Cannabis Research Act of 2019
The Medical Cannabis Research Act, sponsored by Rep. Matt Gaetz (R-FL), would require the Justice Department to approve additional manufacturers of research-grade marijuana, protect research institutions interested in conducting studies on cannabis and authorize the U.S. Department of Veterans Affairs to inform patients about federally approved cannabis studies that they can participate in.
Medical Marijuana Research Act of 2019
A bipartisan group of House members, led by Rep. Earl Blumenauer (D-OR), introduced the bill last year. It would simplify the registration process for researchers interested in studying cannabis and allow certified scientists to obtain research-grade cannabis from private manufacturers.
Legitimate Use of Medicinal Marijuana Act
This legislation, from Rep. Morgan Griffith (R-VA), would move marijuana from Schedule I to Schedule II under the CSA and clarify that the federal government cannot “prohibit or otherwise restrict” state-legal use, possession, transportation, production and distribution of medical cannabis.
Veterans Medical Marijuana Safe Harbor Act
Rep. Barbara Lee (D-CA) is the sponsor of the Veterans Medical Marijuana Safe Harbor Act, a bill that would make it legal under federal law for military veterans to “use, possess, or transport medical marijuana” in state-legal systems. It would also allow Department of Veterans Affairs (VA) doctors to issue medical cannabis recommendations to their patients.
POLITICSCongress Will Debate Two Bills To Legalize Marijuana At Hearing With DEA Witness Next WeekPublished 12 hours ago on January 10, 2020By Kyle Jaeger
SHARETWEET
A congressional committee will debate two bills to federally legalize marijuana and several other pieces of cannabis research legislation next week, according to a briefing memo obtained by Marijuana Moment on Friday.
A House Energy and Commerce subcommittee is scheduled to hold a hearing on various reform proposals on Wednesday, with witnesses from the Drug Enforcement Administration (DEA), Food and Drug Administration (FDA) and National Institute on Drug Abuse (NIDA) set to testify.
This comes months after the House Judiciary Committee held a historic vote approving a comprehensive legalization bill sponsored by the panel’s chairman, Rep. Jerrold Nadler (D-NY). That legislation—the Marijuana Opportunity, Reinvestment and Expungement (MORE) Act—will be one of two descheduling bills the Energy and Commerce Subcommittee on Health will take up.
The memo starts by providing context on the state of cannabis policy in the U.S., outlining research restrictions imposed under the Controlled Substances Act (CSA), the legalization of industrial hemp, past petitions to reschedule cannabis and public health issues.
DEA Senior Policy Advisor Matthew Strait, FDA Deputy Director for Regulatory Programs Douglas Throckmorton and NIDA Director Nora Volkow are listed as witnesses for the hearing.
Here are the bills that the committee will consider next week:
Marijuana Opportunity Reinvestment and Expungement (MORE) Act
The MORE Act would federally deschedule cannabis, expunge the records of those with prior marijuana convictions and impose a five percent tax on sales, revenue from which would be reinvested in communities most impacted by the drug war.
It would also create a pathway for resentencing for those incarcerated for marijuana offenses, as well as protect immigrants from being denied citizenship over cannabis and prevent federal agencies from blocking public benefits or security clearances due to its use.
Marijuana Freedom and Opportunity Act
This bill, sponsored by Rep. Hakeem Jeffries (D-NY), would federally deschedule marijuana, set aside funding for minority and women-owned cannabis businesses and provide grants to help people expunge prior marijuana convictions. Senate Minority Leader Chuck Schumer (D-NY) is the lead sponsor of a companion Senate bill.
Medical Cannabis Research Act of 2019
The Medical Cannabis Research Act, sponsored by Rep. Matt Gaetz (R-FL), would require the Justice Department to approve additional manufacturers of research-grade marijuana, protect research institutions interested in conducting studies on cannabis and authorize the U.S. Department of Veterans Affairs to inform patients about federally approved cannabis studies that they can participate in.
Medical Marijuana Research Act of 2019
A bipartisan group of House members, led by Rep. Earl Blumenauer (D-OR), introduced the bill last year. It would simplify the registration process for researchers interested in studying cannabis and allow certified scientists to obtain research-grade cannabis from private manufacturers.
Legitimate Use of Medicinal Marijuana Act
This legislation, from Rep. Morgan Griffith (R-VA), would move marijuana from Schedule I to Schedule II under the CSA and clarify that the federal government cannot “prohibit or otherwise restrict” state-legal use, possession, transportation, production and distribution of medical cannabis.
Veterans Medical Marijuana Safe Harbor Act
Rep. Barbara Lee (D-CA) is the sponsor of the Veterans Medical Marijuana Safe Harbor Act, a bill that would make it legal under federal law for military veterans to “use, possess, or transport medical marijuana” in state-legal systems. It would also allow Department of Veterans Affairs (VA) doctors to issue medical cannabis recommendations to their patients.
Bahaha lmao
To see this revoked for trading. And I think it’s day will come. $MSPC scam and I’m not sure how you cannot see the scam after all this time.